G1 Believes Boehringer Is Better Bet To Sell Trilaciclib

Drops Plans To Market Alone In US

 
• By Kevin Grogan
  
Hikers
Boehringer gives G1 a helping commercial hand • Source: Shutterstock
Scrip Podcast

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.

SpotifyApple PodcastsWebsite

More from Anticancer

More from Therapeutic Category